The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...

For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary ...

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

According to many experts, Mr. Claus is at risk for lots of serious health conditions due to his less-than-optimal lifestyle.

Clientele are challenging a Fort St. John pharmacy for forcing its customers through its perfume section, with the smells causing problems for those with sensitivities.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Analysts are intrested in these 5 stocks: ( ($CWAN) ), ( ($HTBK) ), ( ($OVID) ), ( ($MCFT) ) and ( ($WHWK) ). Here is a breakdown of their recent ...

Adderall, Ritalin and other stimulants prescribed for attention-deficit/hyperactivity disorder seem to work on brain areas ...

Two new groundbreaking drugs could slow the memory impairment, thinking skills and overall brain decline — and both are ...

Anecdotal stories suggesting that weight-loss drugs can help people shake long-standing addictions have been spreading fast ...